IDO1 and cancer: IDO inhibition by 1MT also cooperates with several chemotherapeutic agents to effectively promote regression of established breast cancer tumors that were previously resistant to chemotherapy, suggesting that, while minimally effective on its own, 1MT intervention may be best used in combination with other anti-cancer therapies [168].